论文部分内容阅读
《Asian Med News》1983;5(9);4。美国马里兰大学(UM)的医学研究人员即将鉴定一种被认为促使发生原发性高血压的新激素。参与此研究的另一研究人员、该大学生理学部主任Mordecai Blaustein告诫说,这仍然是一个假设。但他又说,令人鼓舞的是:最近的试验结果表明与预期的相同。 UM研究小组发现原发性高血压病人的血中似乎含有一种钠钾ATP酶抑制剂。此酶能
Asian Med News 1983; 5 (9); 4. Medical researchers at the University of Maryland (UM) are about to identify a new hormone that is thought to trigger essential hypertension. Mordecai Blaustein, director of the undergraduate physiology department, another researcher involved in the study, cautioned that this remains an assumption. However, he added that it is encouraging to note that the results of the most recent trial showed the same as expected. The UM team found that patients with essential hypertension appear to have a sodium-potassium ATPase inhibitor in their blood. This enzyme can